IXC 2.86% 7.2¢ invex therapeutics ltd

Ann: Invex Granted European Orphan Drug Designation for TBI, page-52

  1. 15,516 Posts.
    lightbulb Created with Sketch. 1282
    100% biotech sector been in a bear market for the last 2 or so years while resources fire. Eventually this tide changes and people will be looking for cashed up near term bios. The best is yet to come. It’s why they say buy when no one wants it…
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.701K 23.62K

Buyers (Bids)

No. Vol. Price($)
2 76375 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.